The acquisition enables Saint-Gobain to expand its capabilities in providing required services needed by the biopharmaceutical industry.

Saint-Gobain Performance Plastics fluid systems division vice president Michael Cahill said asTwinBay Medical shares same passion for customer service, focusing on the quality and reliability of the products.

"Thanks to Saint-Gobain’s global reach, combining the companies will allow us to partner with our global customers wherever they operate," Cahill added.

"We are also very pleased that Twin Bay Medical’s founder, Al Werth, will continue to work with us and will keep bringing innovation within the space of single-use biopharmaceutical manufacturing."